Results 81 to 90 of about 2,016,148 (297)

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

The impact of Angiopoietin-2 genetic polymorphisms on susceptibility for malignant breast neoplasms. [PDF]

Sci Rep, 2022
Hu GN, Wang Y, Tang CH, Jin LL, Huang BF, Wang Q, Shao JK, Wang CQ, Su CM.   +8 more
europepmc   +1 more source

Hepar Lobatum Carcinomatosum Revealing a Breast Neoplasm: Case Report

, 2022
Y. Ennaich, N. Benarbia, H. Hajar, H. Tabakh, O. Kacimi, A. Siwane, N. Touil, N. Chikhaoui   +7 more
openalex   +1 more source

Assistência multiprofissional na prevenção de neoplasias mamárias no sexo masculino / Multiprofessional assistance in the prevention of breast neoplasms in male [PDF]

, 2021
Ismael Carlos Santos Rodrigues, Natalie Rosa Pires Neves, Derek Klinger Buás Pinto, Bethina Brandão Silva, Luis Antonio Danrley de Jesus Costa dos Santos, Luís Victor Moraes de Moura, Renata dos Santos de Sousa, Michelle Mota de Sousa   +7 more
openalex   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Molecular breast imaging and background uptake of fibroglandular tissue as tools to predict neoplasms in dense breasts

, 2021
Carla Lima Santos Viviani, Lucimara Priscila Campos Veras, Dionísio Nepomuceno Viviani, Amanda Sofia Silva Mascarenhas, Rivadávio Fernandes Batista de Amorim   +4 more
openalex   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Oral Soft Tissue Metastasis from Breast Cancer as the Only Primary Source: Systematic Review

Avicenna Journal of Medicine
Background Breast cancer is one of the most lethal neoplasms causing death. Oral cavity is the rare site of distant metastasis from breast cancer.
Nausheen Aga, Ruchira Shreevats, Sonia Gupta, Harman Sandhu, Muna E.M. Hassan, Harnisha V. Prajapati   +5 more
doaj   +1 more source

Scientometric analysis of lipid metabolism in breast neoplasm: 2012–2021 [PDF]

, 2023
Xiaobing Lin, Qiuping Yang, Daitian Zheng, Huiting Tian, Lingzhi Chen, Jinyao Wu, Zeqi Ji, Yexi Chen, Zhiyang Li   +8 more
openalex   +1 more source